Parents in California who have children who get chronic ear infections will soon have a more convenient way to get their kids care.
San Francisco-based CellScope, a Khosla Ventures-backed Rock Health alum, has begun taking preorders for its FDA registered smartphone-enabled otoscope, called Oto Home. The director-to-consumer device is priced at $79 and will ship in four to six weeks. A feature-...
